Good Neighbor Pharmacy Lubricant Eye Drops

Ophthalmic Lubrication (Dry Eye)

For the treatment of mild to moderate dry eye symptoms, the standard dosage is 1 to 2 drops in the affected eye(s) as needed. Patients with chronic ocular surface disease may require more frequent application, sometimes up to 4 to 6 times daily. If using a high-viscosity gel form, application is typically limited to once or twice daily, often before bedtime, due to potential temporary blurring of vision.

Allergy Testing (Diagnostic)

Dosage for diagnostic purposes is highly individualized and must be performed by a specialist. For patch testing, a small amount of the standardized extract (often 10% in petrolatum) is applied to the back under an occlusive dressing for 48 hours. For intradermal testing, minute volumes (e.g., 0.02 mL) of a sterile solution are injected into the dermis to observe for a wheal-and-flare reaction.

Carboxymethylcellulose Sodium is generally considered safe for use in children when used as an ophthalmic lubricant. The dosage is typically the same as the adult dose (1-2 drops as needed). However, safety and efficacy for diagnostic allergy testing in children under the age of 6 have not been extensively documented in large-scale clinical trials; therefore, pediatric allergy testing must be conducted under strict medical supervision.

Renal Impairment

Because Carboxymethylcellulose Sodium is not systemically absorbed, no dosage adjustments are required for patients with renal (kidney) impairment. There is no risk of accumulation in the kidneys.

Hepatic Impairment

No dosage adjustments are necessary for patients with hepatic (liver) impairment, as the drug does not undergo hepatic metabolism or biliary excretion.

Elderly Patients

No specific dosage reductions are recommended for geriatric patients. However, elderly patients may be more prone to dry eye symptoms due to age-related changes in tear production and may require more frequent application of the lubricant.

Ophthalmic Administration

1. 1Wash hands thoroughly before use.
2. 2Tilt the head back and pull down the lower eyelid to create a small pocket.
3. 3Hold the dropper bottle or vial above the eye, being careful not to touch the tip to the eye, eyelashes, or any other surface (to prevent contamination).
4. 4Squeeze the prescribed number of drops into the pocket.
5. 5Close the eye gently for 1-2 minutes and apply light pressure to the lacrimal duct (the corner of the eye near the nose) to keep the medication on the ocular surface.
6. 6If using other eye medications, wait at least 5 to 10 minutes between applications.

Storage Conditions

Store at room temperature (15°C to 30°C or 59°F to 86°F). Protect from freezing and excessive heat. For preservative-free single-use vials, discard the vial immediately after a single use, even if some solution remains.

Since CMC is primarily used on an 'as-needed' basis for symptom relief, a missed dose is not clinically significant. Simply apply the drops when you remember or when symptoms of dryness recur. Do not 'double up' the dose to make up for a missed application.

An overdose of Carboxymethylcellulose Sodium via the ophthalmic route is highly unlikely to cause systemic toxicity. Excessive application to the eye may result in temporary blurred vision or a sticky sensation on the eyelids. If the solution is accidentally ingested, it generally passes through the digestive tract without harm, though large quantities might cause mild gastrointestinal upset or a laxative effect. In case of accidental ingestion by a child, contact a Poison Control Center as a precaution.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

When used as an ophthalmic lubricant, the most frequently reported side effects are localized to the eye and are generally transient. These include:

• Temporary Blurred Vision: This is especially common with higher viscosity 'Gel' formulations. It typically lasts for 1 to 5 minutes after application as the polymer spreads across the cornea.
• Ocular Discomfort: A mild stinging or burning sensation may occur immediately upon instillation.
• Eye Discharge: Some patients may notice a slight 'crusting' on the eyelashes or the corners of the eyes as the solution dries.

• Eye Irritation: Persistent redness or a feeling of a foreign body in the eye.
• Eyelid Edema: Mild swelling of the eyelids.
• Increased Lacrimation: Paradoxical watery eyes following application.
• Photophobia: Increased sensitivity to light.

• Allergic Conjunctivitis: Inflammation of the conjunctiva due to a specific sensitivity to the CMC polymer or the preservatives (such as Purite or Benzalkonium Chloride) found in multi-dose bottles.
• Severe Eye Pain: Sharp pain that persists long after the drops have been applied.
• Vision Changes: A significant decrease in visual acuity that does not resolve within minutes.

While Carboxymethylcellulose Sodium is exceptionally safe, systemic hypersensitivity (anaphylaxis) has been documented in rare clinical case reports, particularly when the substance is used as an excipient in injectable medications.

> Warning: Stop taking Carboxymethylcellulose Sodium, Unspecified Form and call your doctor immediately if you experience any of these:

• Signs of Anaphylaxis: Hives, generalized itching, swelling of the face, lips, or tongue, and difficulty breathing or swallowing.
• Acute Vision Loss: Sudden inability to see clearly that is not related to the initial application of the drops.
• Severe Ocular Hyperemia: Intense redness of the eye accompanied by pain and discharge, which may indicate an infection or a severe reaction.

Prolonged use of Carboxymethylcellulose Sodium is generally considered safe and is often necessary for the management of chronic dry eye. However, long-term use of multi-dose bottles containing certain preservatives (like Benzalkonium Chloride) can lead to corneal epithelial damage or 'medicamentosa' (drug-induced inflammation). For patients requiring long-term therapy more than 4 times daily, preservative-free formulations are strongly recommended to avoid these chronic ocular surface changes.

There are currently no FDA Black Box Warnings for Carboxymethylcellulose Sodium, Unspecified Form. It is regarded as one of the safest pharmacological agents in ophthalmic and diagnostic use.

Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.

Carboxymethylcellulose Sodium, Unspecified Form, is intended for topical ophthalmic or diagnostic use only. It should not be injected into the eye or taken orally unless specifically directed by a healthcare professional in a clinical setting. Patients must ensure that the product is not contaminated; if the solution changes color or becomes cloudy, it should be discarded immediately. Furthermore, if symptoms of dry eye worsen or persist for more than 72 hours, a comprehensive eye examination is necessary to rule out underlying conditions such as Sjögren's syndrome or bacterial keratitis.

No FDA black box warnings for Carboxymethylcellulose Sodium, Unspecified Form.

Allergic Reactions / Anaphylaxis Risk

Although CMC is used as a diagnostic allergen, it can also cause unexpected allergic reactions. Patients with a known history of sensitivity to other cellulose derivatives (such as methylcellulose or hydroxypropyl methylcellulose) should exercise caution. Rare cases of systemic anaphylaxis have occurred when CMC was present as an excipient in corticosteroid injections. If you have a history of severe drug allergies, inform your doctor before undergoing testing with CMC.

Contamination Risk

To avoid serious ocular infections, the tip of the dispensing container must never touch any surface, including the eye itself. Use of contaminated eye drops can lead to corneal ulcers and potential vision loss. Multi-dose bottles should be discarded within the timeframe specified by the manufacturer (usually 30 to 90 days after opening).

Contact Lens Wear

Some formulations of CMC contain preservatives that can be absorbed by soft contact lenses. Generally, it is advised to remove contact lenses before instilling the drops and wait at least 15 minutes before reinserting them. However, many 'preservative-free' CMC products are specifically marketed as safe for use with contact lenses; always check the specific product labeling.

There are no specific laboratory monitoring requirements (such as blood counts or liver enzymes) for the use of Carboxymethylcellulose Sodium due to its lack of systemic absorption. However, patients using it for dry eye should have regular ophthalmic examinations to monitor corneal health and tear film stability. For those undergoing allergy testing, monitoring of vital signs during the procedure is standard practice to manage any potential systemic reactions.

Carboxymethylcellulose Sodium may cause transient blurring of vision immediately after application. Patients should not drive, operate heavy machinery, or engage in any hazardous activities until their vision has cleared completely. This usually occurs within a few minutes but may take longer with high-viscosity gel formulations.

There are no known interactions between alcohol consumption and the use of topical Carboxymethylcellulose Sodium. Because the drug is not systemically absorbed, alcohol does not affect its pharmacokinetics or pharmacodynamics.

There is no risk of withdrawal syndrome or rebound effect upon discontinuing Carboxymethylcellulose Sodium. However, symptoms of dry eye or ocular irritation are likely to return if the underlying cause of the dryness has not been addressed.

> Important: Discuss all your medical conditions with your healthcare provider before starting Carboxymethylcellulose Sodium, Unspecified Form.

There are no known absolute contraindications for combining Carboxymethylcellulose Sodium with other medications. Because it acts physically rather than chemically and is not absorbed into the bloodstream, it does not interfere with the systemic action of other drugs.

While no serious systemic interactions exist, the physical presence of CMC on the eye can affect the absorption of other topical ophthalmic medications. If CMC is applied simultaneously with a medicated eye drop (such as a glaucoma medication or antibiotic), it may create a physical barrier or dilute the active medication, potentially reducing its efficacy.

Management: Always wait at least 5 to 10 minutes between the application of Carboxymethylcellulose Sodium and any other ophthalmic medication. Generally, the medicated drop should be applied first, followed by the lubricant.

Ophthalmic Ointments

If you are using both CMC drops and an ophthalmic ointment, the drops should be used first. Ointments have a thick, petrolatum base that will prevent the CMC drops from reaching the corneal surface if applied afterward.

There are no known food interactions with topical Carboxymethylcellulose Sodium. When CMC is used as a food additive, it is considered inert and does not interact with the absorption of nutrients, although as a soluble fiber, it could theoretically slow the absorption of some highly lipophilic substances if consumed in very large quantities.

No interactions have been documented between Carboxymethylcellulose Sodium and herbal supplements such as St. John's Wort, Ginkgo Biloba, or Valerian root. The localized nature of CMC's action precludes systemic interaction with these substances.

Carboxymethylcellulose Sodium does not interfere with standard blood or urine laboratory tests. However, its presence on the ocular surface might interfere with certain specialized ophthalmic diagnostic tests, such as tear film osmolarity testing or certain types of corneal staining, if applied immediately before the test. Inform your ophthalmologist if you have used lubricant drops on the day of your eye exam.

Summary of Interaction Mechanism

• Mechanism: Physical barrier and dilution (Pharmacodynamic).
• Clinical Consequence: Potential reduction in the concentration of co-administered ophthalmic drugs.
• Management Strategy: Stagger administration by 10 minutes.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Carboxymethylcellulose Sodium, Unspecified Form, must NEVER be used in the following circumstances:

• Hypersensitivity: Known severe allergy to Carboxymethylcellulose Sodium or any of the inactive ingredients (such as specific preservatives like Purite or Benzalkonium Chloride) in the formulation. An absolute contraindication exists if a patient has previously experienced anaphylaxis or severe angioedema (swelling) specifically linked to this polymer.
• Contaminated Product: Use of the product is absolutely contraindicated if the solution has become cloudy, changed color, or if the container's integrity has been compromised, as this poses a high risk of bacterial endophthalmitis (internal eye infection).

Conditions requiring careful risk-benefit analysis include:

• Active Ocular Infection: While CMC is not harmful, using a multi-dose bottle during an active viral or bacterial infection can lead to re-infection or cross-contamination. Single-use vials are preferred in these scenarios.
• Post-Surgical Ocular Surface: Immediately following certain delicate ocular surgeries (like corneal transplants), the use of specific polymers must be cleared by the surgeon to ensure they do not interfere with the healing of the surgical incision.

Patients who are allergic to other cellulose ethers may exhibit cross-sensitivity to Carboxymethylcellulose Sodium. These related substances include:

• Methylcellulose
• Hydroxypropyl Methylcellulose (Hypromellose)
• Ethylcellulose
• Hydroxyethyl Cellulose

If you have had a reaction to 'artificial tears' in the past, it is vital to identify which specific cellulose derivative was used to avoid a cross-reactive inflammatory response.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Carboxymethylcellulose Sodium, Unspecified Form.

Pregnancy Category: Not Classified (Generally considered safe).

Carboxymethylcellulose Sodium is not systemically absorbed following topical ophthalmic or oral administration. Consequently, there is no measurable exposure to the developing fetus. There are no known teratogenic effects associated with CMC. It is widely used by pregnant women for the relief of dry eye, which can be exacerbated by hormonal changes during pregnancy. As with all medications, use during pregnancy should be discussed with a healthcare provider, but the risk profile is considered negligible.

It is not known whether CMC is excreted in human milk; however, because there is no systemic absorption from the eye or gut, it is physiologically impossible for clinically significant amounts to reach the breast milk. There are no known risks to the nursing infant. Carboxymethylcellulose Sodium is considered compatible with breastfeeding.

CMC is frequently used in children to treat ocular irritation caused by allergies, screen time, or environmental factors. It is generally safe for all age groups. However, parents should administer the drops to ensure the dropper tip does not touch the child's eye. For diagnostic allergy testing, the safety and efficacy have not been established in infants, and such procedures should only be conducted by a pediatric allergist.

Elderly patients often suffer from decreased tear production (aqueous deficient dry eye) and may benefit significantly from CMC. No dosage adjustments are required. However, elderly patients with arthritic hands may find it difficult to squeeze small dropper bottles and may require assistive devices or preservative-free vials that are easier to manipulate. There is no increased risk of systemic side effects in the elderly due to the lack of absorption.

No adjustments are necessary. CMC does not enter the systemic circulation and therefore does not place any burden on the kidneys. It is safe for patients on hemodialysis or those with end-stage renal disease (ESRD).

No adjustments are necessary. CMC is not processed by the liver. It is safe for patients with cirrhosis or other forms of hepatic dysfunction.

> Important: Special populations require individualized medical assessment.

Carboxymethylcellulose Sodium is a long-chain polymer of β-D-glucose units. Its primary pharmacological action is mucoadhesion. The polymer contains multiple carboxyl groups (-COOH) that interact with the mucin layer of the tear film and the glycocalyx of the corneal epithelial cells. By mimicking the action of natural mucins, CMC stabilizes the tear film and increases the 'break-up time' (TBUT), which is a clinical measure of how long the tear film remains intact on the eye. At the molecular level, it provides a protective matrix that traps water, reducing the osmolarity of the tear film, which is often pathologically high in dry eye patients.

The dose-response relationship for CMC is related to its viscosity. Higher concentrations (e.g., 1.0%) provide longer-lasting relief but cause more significant temporary blurring than lower concentrations (0.5%). The onset of effect is immediate upon instillation. The duration of effect typically lasts between 30 minutes and 2 hours, depending on the severity of the patient's tear deficiency and environmental conditions (e.g., humidity, wind).

| Parameter | Value |

|---|---|

| Bioavailability | 0% (Topical/Oral) |

| Protein Binding | N/A (Not absorbed) |

| Half-life (Ocular) | 15–45 minutes (Retention time) |

| Tmax | Immediate (Local) |

| Metabolism | None |

| Excretion | Nasolacrimal drainage / Fecal (if ingested) |

• Molecular Formula: [C6H7O2(OH)x(OCH2COONa)y]n
• Molecular Weight: Varies widely (typically 90,000 to 700,000 Daltons)
• Solubility: Highly soluble in water; forms a viscous, colloidal solution.
• Structure: A semi-synthetic, water-soluble polymer in which CH2COONa groups are substituted on the glucose units of the cellulose chain.

Carboxymethylcellulose Sodium belongs to the therapeutic class of Ophthalmic Lubricants and the diagnostic class of Standardized Chemical Allergens. It is often grouped with other artificial tears such as Polyvinyl Alcohol, Glycerin, and Propylene Glycol.